A-Kinase Anchor Protein 95 Is Involved in ERK1/2-Elk-1 Signal Transduction in Colon Cancer
- PMID: 36691407
- PMCID: PMC9867590
- DOI: 10.1155/2023/8242646
A-Kinase Anchor Protein 95 Is Involved in ERK1/2-Elk-1 Signal Transduction in Colon Cancer
Abstract
Objectives: To assess A-kinase anchor protein 95 (AKAP95), B-Raf, extracellular regulated protein kinases 1/2 (ERK1/2), and Elk-1 expression in colon cancer tissue, and characterize AKAP95 associations with B-Raf, ERK1/2, Elk-1, and colon cancer clinicopathological indices.
Methods: The immunohistochemistry streptavidin-perosidase (SP) method was used to determine protein expression levels in 64 colon cancer and 32 para-carcinoma tissue specimens.
Results: (1) Positive AKAP95 expression rates in colon cancer tissue were higher when compared with para-carcinoma tissue (92.19% vs. 59.38%, P < 0.05). Similar findings were determined for B-Raf (76.56% vs. 25%, P < 0.05), ERK1/2 (90.63% vs. 31.25%, P < 0.05), and Elk-1 levels (92.19% vs. 40.63%, P < 0.05). (2) No significant associations were identified between AKAP95, B-Raf, ERK1/2, and Elk-1 protein expression and degree of differentiation, histological type, and lymph node metastasis in colon cancer samples (P > 0.05); however, in The Cancer Genome Atlas and Gene Expression Omnibus datasets, AKAP95 was closely related to immune infiltration, and highly expressed AKAP95 was negatively associated with overall survival and relapse free survival rates in colon cancer patients. (3) Correlations were observed between AKAP95 and ERK1/2, AKAP95 and Elk-1, B-Raf and ERK1/2, B-Raf and Elk-1, and ERK1/2 and Elk-1 (all P < 0.05), but no correlation was observed between AKAP95 and B-Raf (P > 0.05).
Conclusions: AKAP95 may affect immune infiltration levels in colon cancer by participating in ERK1/2-Elk-1 signal transduction.
Copyright © 2023 Xiangyu Kong et al.
Conflict of interest statement
The author(s) declare(s) that they have no conflicts of interest.
Figures

Similar articles
-
[Expression of A-kinase anchor protein 95, cyclin E2, and connexin 43 in lung cancer tissue, clinical significance of their expression, and their expression correlation].Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi. 2012 Oct;30(10):725-9. Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi. 2012. PMID: 23256994 Chinese.
-
Synergistic effects of AKAP95, Cyclin D1, Cyclin E1, and Cx43 in the development of rectal cancer.Int J Clin Exp Pathol. 2015 Feb 1;8(2):1666-73. eCollection 2015. Int J Clin Exp Pathol. 2015. PMID: 25973052 Free PMC article.
-
[Relationship between AKAP95, cyclin E1, cyclin D1, and clinicopathological parameters in lung cancer tissue].Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi. 2013 Dec;31(12):890-4. Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi. 2013. PMID: 24370359 Chinese.
-
Targeting ERK1/2 protein-serine/threonine kinases in human cancers.Pharmacol Res. 2019 Apr;142:151-168. doi: 10.1016/j.phrs.2019.01.039. Epub 2019 Feb 20. Pharmacol Res. 2019. PMID: 30794926 Review.
-
ERK1/2 MAP kinases: structure, function, and regulation.Pharmacol Res. 2012 Aug;66(2):105-43. doi: 10.1016/j.phrs.2012.04.005. Epub 2012 Apr 27. Pharmacol Res. 2012. PMID: 22569528 Review.
Cited by
-
Integrative analysis identifies AKAP8L as an immunological and prognostic biomarker of pan-cancer.Aging (Albany NY). 2023 Sep 7;15(17):8851-8872. doi: 10.18632/aging.205003. Epub 2023 Sep 7. Aging (Albany NY). 2023. PMID: 37683130 Free PMC article.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Molecular Biology Databases
Research Materials
Miscellaneous